Loss of Par-4 expression by diverse mechanisms, including methylation-dependent downregulation of the Par-4 promoter, inactivation of Par-4 protein by Akt-mediated phosphorylation, or spontaneous mutation, has been associated with diverse human cancers (2–5). The gene discussed is F2RL3; the disease is cancer.